$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC.

2023 Q4 Form 10-Q Financial Statement

#000164033423001850 Filed on October 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q2
Revenue $28.96K $31.11K
YoY Change -17.19% -3.61%
Cost Of Revenue $17.67K $15.96K
YoY Change 92.69% 6.68%
Gross Profit $11.29K $15.15K
YoY Change -56.24% -12.5%
Gross Profit Margin 38.98% 48.7%
Selling, General & Admin $68.08K $51.37K
YoY Change 4.79% -4.16%
% of Gross Profit 603.01% 339.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $68.08K $51.37K
YoY Change 4.77% 3.36%
Operating Profit -$56.79K -$36.22K
YoY Change 44.95% 11.85%
Interest Expense $489.3K $66.66K
YoY Change -34.22% -2.86%
% of Operating Profit
Other Income/Expense, Net $609.6K
YoY Change -37.33%
Pretax Income $432.5K $573.4K
YoY Change -38.62% -39.02%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $432.5K $573.4K
YoY Change -38.62% -39.02%
Net Earnings / Revenue 1493.51% 1843.3%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 3.712B shares
Diluted Shares Outstanding 10.37B shares

Balance Sheet

Concept 2023 Q4 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.300K $3.410K
YoY Change -47.05% -86.72%
Cash & Equivalents $5.295K $3.411K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.295K $3.411K
YoY Change -47.1% -89.72%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.00 -$1.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $5.295K $3.411K
Total Long-Term Assets $5.00 -$1.00
Total Assets $5.300K $3.410K
YoY Change -47.05% -89.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $652.6K $644.7K
YoY Change 12.57% 28.9%
Accrued Expenses $669.0K $552.6K
YoY Change 51.06% 65.05%
Deferred Revenue
YoY Change
Short-Term Debt $1.044M $978.3K
YoY Change 12.89% 11.42%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.204M $4.407M
YoY Change -14.45% -13.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.204M $4.407M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $4.204M $4.407M
YoY Change -14.45% -13.38%
SHAREHOLDERS EQUITY
Retained Earnings -$9.303M -$9.442M
YoY Change -6.44% -5.36%
Common Stock $3.897M $3.712M
YoY Change 4.99% 4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.199M -$4.403M
YoY Change
Total Liabilities & Shareholders Equity $5.295K $3.411K
YoY Change -47.1% -89.72%

Cashflow Statement

Concept 2023 Q4 2023 Q2
OPERATING ACTIVITIES
Net Income $432.5K $573.4K
YoY Change -38.62% -39.02%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$56.86K $3.500K
YoY Change 169.61% -110.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 59.00K -900.0
YoY Change 218.57% -102.0%
NET CHANGE
Cash From Operating Activities -56.86K 3.500K
Cash From Investing Activities 0.000
Cash From Financing Activities 59.00K -900.0
Net Change In Cash 2.140K 2.600K
YoY Change -183.27% -76.08%
FREE CASH FLOW
Cash From Operating Activities -$56.86K $3.500K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Central Index Key
EntityCentralIndexKey
0001407704
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3711714036 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3711714036 shares
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
2907433 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55498
dei Entity Registrant Name
EntityRegistrantName
LINGERIE FIGHTING CHAMPIONSHIPS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8009362
dei Entity Address Address Line1
EntityAddressAddressLine1
6955 North Durango Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1115-129
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89149
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
505-0743
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3711714036 shares
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3411 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10009 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
3411 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
10009 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
51471 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
37098 usd
CY2023Q2 boty Accounts Payable Related Parties
AccountsPayableRelatedParties
593268 usd
CY2022Q4 boty Accounts Payable Related Parties
AccountsPayableRelatedParties
542668 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
552569 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
442888 usd
CY2023Q2 boty Promissory Notes Payable Current
PromissoryNotesPayableCurrent
365000 usd
CY2022Q4 boty Promissory Notes Payable Current
PromissoryNotesPayableCurrent
340000 usd
CY2023Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
613289 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
584730 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2231144 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2967243 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4406741 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4914627 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
3711715 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3711715 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1327104 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1327104 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9442149 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9943437 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4403330 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4904618 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3411 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10009 usd
CY2023Q2 us-gaap Revenues
Revenues
31108 usd
CY2022Q2 us-gaap Revenues
Revenues
32273 usd
us-gaap Revenues
Revenues
56303 usd
us-gaap Revenues
Revenues
53438 usd
CY2023Q2 boty Cost Of Service
CostOfService
15957 usd
CY2022Q2 boty Cost Of Service
CostOfService
14957 usd
boty Cost Of Service
CostOfService
40803 usd
boty Cost Of Service
CostOfService
14957 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
15151 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
17316 usd
us-gaap Gross Profit
GrossProfit
15500 usd
us-gaap Gross Profit
GrossProfit
38481 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8822 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23599 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26926 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38511 usd
CY2023Q2 boty Professional Fee
ProfessionalFee
12548 usd
CY2022Q2 boty Professional Fee
ProfessionalFee
-3900 usd
boty Professional Fee
ProfessionalFee
25146 usd
boty Professional Fee
ProfessionalFee
32000 usd
CY2023Q2 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
CY2022Q2 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
us-gaap Salaries And Wages
SalariesAndWages
60000 usd
us-gaap Salaries And Wages
SalariesAndWages
60000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
51370 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
49699 usd
us-gaap Operating Expenses
OperatingExpenses
112072 usd
us-gaap Operating Expenses
OperatingExpenses
130511 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-36219 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-32383 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-96572 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-92030 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
66656 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
68617 usd
us-gaap Interest Expense
InterestExpense
138239 usd
us-gaap Interest Expense
InterestExpense
181108 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
676289 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
1041322 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
736099 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
2017446 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
609633 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
972705 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
597860 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1836338 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
573414 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
940322 usd
us-gaap Profit Loss
ProfitLoss
501288 usd
us-gaap Profit Loss
ProfitLoss
1744308 usd
CY2023Q2 boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
0.00
CY2022Q2 boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
0.00
boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
0.00
boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3711714036 shares
CY2022Q2 boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3535302536 shares
boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3711714036 shares
boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3535302536 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10370856034 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10102741582 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10370856034 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10102741582 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4904618 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-72126 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4976744 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
573414 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4403330 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6798809 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
803986 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-5994823 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
940322 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5054502 usd
us-gaap Net Income Loss
NetIncomeLoss
501288 usd
us-gaap Net Income Loss
NetIncomeLoss
1744308 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-736099 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-2017446 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
28558 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
78170 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
50600 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
35000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14374 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3219 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
109681 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
102938 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31598 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53811 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
45000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6598 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8811 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10009 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34481 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3411 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25670 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
boty Debt Discount From Derivative Liabilities
DebtDiscountFromDerivativeLiabilities
0 usd
boty Debt Discount From Derivative Liabilities
DebtDiscountFromDerivativeLiabilities
52000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3411 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10009 usd
us-gaap Revenues
Revenues
56303 usd
us-gaap Revenues
Revenues
53438 usd
us-gaap Cost Of Revenue
CostOfRevenue
40803 usd
us-gaap Cost Of Revenue
CostOfRevenue
14957 usd
us-gaap Gross Profit
GrossProfit
15500 usd
us-gaap Gross Profit
GrossProfit
38481 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6659141998 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6567439047 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3711714036 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5556666666 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
CY2022 boty Number Of Shares Granted
NumberOfSharesGranted
282080000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0005
CY2022 boty Exercised
Exercised
-201613143 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0001
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5637133523 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5637133523 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
boty Expected Term
ExpectedTerm
P2Y5M1D
boty Expected Term
ExpectedTerm
P3Y2M4D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
474839 usd
CY2023Q2 boty Closing Market Price
ClosingMarketPrice
0.0002
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5637133523 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1085001 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1683773 shares
CY2020Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2225000000 shares
us-gaap Interest And Debt Expense
InterestAndDebtExpense
82042 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
76755 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2967243 usd
boty Gain On Change In Fair Value Of The Derivative
GainOnChangeInFairValueOfTheDerivative
-736099 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2231144 usd
boty Day One Loss Due To Derivative Liabilities On Convertible Notes And Warrant
DayOneLossDueToDerivativeLiabilitiesOnConvertibleNotesAndWarrant
0 usd
boty Day One Loss Due To Derivative Liabilities On Convertible Notes And Warrant
DayOneLossDueToDerivativeLiabilitiesOnConvertibleNotesAndWarrant
72101 usd
boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
-137327 usd
boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
-2089547 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-137327 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-2017446 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y4M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y10M17D
boty Expected Dividend Yield
ExpectedDividendYield
0 pure
boty Expected Dividend Yield
ExpectedDividendYield
0 pure
CY2023Q2 boty Amount Due To Related Parties
AmountDueToRelatedParties
593268 usd
CY2022Q4 boty Amount Due To Related Parties
AmountDueToRelatedParties
542668 usd

Files In Submission

Name View Source Status
0001640334-23-001850-index-headers.html Edgar Link pending
0001640334-23-001850-index.html Edgar Link pending
0001640334-23-001850.txt Edgar Link pending
0001640334-23-001850-xbrl.zip Edgar Link pending
boty-20230630.xsd Edgar Link pending
boty-20230630_cal.xml Edgar Link unprocessable
boty-20230630_def.xml Edgar Link unprocessable
boty-20230630_lab.xml Edgar Link unprocessable
boty-20230630_pre.xml Edgar Link unprocessable
boty_10q.htm Edgar Link pending
boty_ex311.htm Edgar Link pending
boty_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
boty_10q_htm.xml Edgar Link completed